Specifically, several studies using large cohorts of breast cancer patients have revealed that the expression of CD68 in tumor tissue is associated with higher grade [22, 23], increased angiogenesis [24–26], and reduced disease-free survival [25, 27, 28]. This evidence concerns the gene CD68 and breast carcinoma.